Stanley Tennant, Director at TrovaGene Inc. (TROV), bought 25,000 shares at $4.82 ($121K) on 2012-11-30, disclosed to the SEC on 2012-12-03.
Open-market purchase of $120k TROV by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| TROV | BUY | 2016-12-19 | $30K | — | Filing → |
| TROV | BUY | 2016-12-19 | $21K | — | Filing → |
| TROV | BUY | 2015-08-12 | $61K | — | Filing → |